Coagulation reference ranges: Difference between revisions
No edit summary |
mNo edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 18: | Line 18: | ||
|g/L | |g/L | ||
|1.5-4.0 | |1.5-4.0 | ||
| | | rowspan="6" | | ||
|- | |- | ||
|TCT | |TCT | ||
|Seconds | |Seconds | ||
|< 21 | |< 21 | ||
|- | |- | ||
|TCT + PRSO4 | |TCT + PRSO4 | ||
|Seconds | |Seconds | ||
|< 25 | |< 25 | ||
|- | |- | ||
|D | |D-dimer <50yrs | ||
|ug/L | |ug/L | ||
|< 500 | |< 500 | ||
|- | |- | ||
|D | |D-dimer >50yrs | ||
|ug/L | |ug/L | ||
|Decade x 10 | |Decade x 10 | ||
|- | |- | ||
|FVIII | |FVIII | ||
|iu/dl | |iu/dl | ||
|50 - 150 | |50 - 150 | ||
|} | |} | ||
<nowiki>*</nowiki><small>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.</small> | <nowiki>*</nowiki><small>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.</small> | ||
<small>References:</small> | |||
<small>Northern Haematology Quality Assurance Group. (2017). ''Consensus guidelines: Haematology reference ranges'' (Version 1.0).</small> | |||
Latest revision as of 15:52, 17 November 2026
| Parameter | Units | Normal range | Therapeutic range |
| INR | Ratio | 0.8 - 1.2 | 2.0 - 3.0* |
| APTT | Seconds | 24-38 | 50 - 85 secs |
| FIBRINOGEN | g/L | 1.5-4.0 | |
| TCT | Seconds | < 21 | |
| TCT + PRSO4 | Seconds | < 25 | |
| D-dimer <50yrs | ug/L | < 500 | |
| D-dimer >50yrs | ug/L | Decade x 10 | |
| FVIII | iu/dl | 50 - 150 |
*The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.
References:
Northern Haematology Quality Assurance Group. (2017). Consensus guidelines: Haematology reference ranges (Version 1.0).